The World Health Organisation (WHO) has issued a medical product alert on falsified semaglutides, the type of medicines that are used for the treatment of type 2 diabetes and obesity in some countries.
Trending
- Dangote’s children support plan to give one-third of $36.5bn fortune to charity
- Naira gains further against Pound, hits ₦1,814/£ amid improved FX liquidity
- Northern Security Trust Fund: ₦1bn is a beginning, not the solution [III], by Prof. M. K. Othman
- COSA appeals for urgent intervention after rainstorm damages 68 houses in Kuta
- Fintiri wins AAIS award for food security leadership
- WHO urges faster action to end viral hepatitis, cut liver cancer deaths
- NAFDAC seals 3 Ogun factories over banned sachet, small PET alcohol
- Friends of Soludo couple hold free surgeries for birthdays
